PATENT CLAIM ANALYSIS

Application Number: 16176338
Application Type: Utility
Filing Date: 2018-10
Publication Date: 2019-02
Patent Classification: ["424", "468000"]

Abstract:
The instant invention is generally directed to a patient-friendly drug delivery system for targeted populations, such as pediatric and geriatric patients. Specifically, the present invention relates to a pharmaceutical composition in the form of mini-tablets. Even more specifically, the present invention relates to a pharmaceutical composition comprising a therapeutically-effective amount of melatonin in the form of mini-tablets.

Claim (Index 6):
The controlled-release melatonin mini-tablet of  claim 4 , wherein the ammonio methacrylate copolymer is ammonio methacrylate copolymer type B.

Metadata:
- Claim Count in Document: 16.0
- Percentile: 97.0
- Lexical Diversity: 1.575
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14482160', '12144453', '10269551', '14383462', '10895984']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7437022438453825
- 35 USC 102 Novelty (BERT): 0.511992238773936
- Combined Prediction Score: 0.7205312433382379
- Mean Citation Score: 230.050276
- Max Citation Score: 244.61156
- Similarity Product: 164.41624712584968

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test